{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:59:50Z","timestamp":1762642790518,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bcmd.2022.102709","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T02:20:11Z","timestamp":1667874011000},"page":"102709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rheumatological manifestations of chronic graft versus host disease - Case series"],"prefix":"10.1016","volume":"98","author":[{"given":"Jaros\u0142aw","family":"Sabela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-6415","authenticated-orcid":false,"given":"Jakub","family":"Wro\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Karakulska-Prystupiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Stasiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2022.102709_bb0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5045\/kjh.2011.46.2.80","article-title":"The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma","volume":"46","author":"Min","year":"2011","journal-title":"Korean J. Hematol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2022.102709_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exphem.2005.12.011","article-title":"The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery","volume":"34","author":"Patriarca","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.23885","article-title":"Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria","volume":"90","author":"Kuzmina","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/TP.0b013e3181ac6885","article-title":"Clinical significance of autoantibody expression in allogeneic stem-cell recipients","volume":"88","author":"Moon","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bcmd.2022.102709_bb0030","article-title":"Anti-Ro52 autoantibodies are related to chronic graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0035","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbmt.2010.03.023","article-title":"Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation","volume":"16","author":"Imanguli","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2022.102709_bb0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archderm.138.7.924","article-title":"Sclerodermatous graft-vs-host disease","volume":"138","author":"Pe\u00f1as","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/keg025","article-title":"Polymyositis as a manifestation of chronic graft-versus-host disease","volume":"42","author":"Stevens","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcmd.2022.102709_bb0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/annrheumdis-2019-215024","article-title":"Video clip assessment of a salivary gland ultrasound scoring system in Sj\u00f6gren's syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise","volume":"78","author":"Jousse-Joulin","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcmd.2022.102709_bb0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.berh.2008.09.001","article-title":"Capillaroscopy","volume":"22","author":"Cutolo","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/00313029700169834","article-title":"Autoantibody formation after allogeneic bone marrow transplantation: correlation with the reconstitution of CD5+ B cells and occurrence of graft-versus-host disease","volume":"29","author":"Chan","year":"1997","journal-title":"Pathology"},{"key":"10.1016\/j.bcmd.2022.102709_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2257.2005.00699.x","article-title":"Occurrence of autoantibodies in chronic graft vs. Host disease after allogeneic stem cell transplantation","volume":"27","author":"Wechalekar","year":"2005","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0070","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1631\/jzus.B1900205","article-title":"Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation","volume":"20","author":"Hao","year":"2019","journal-title":"J. Zhejiang Uni.Sci. B"},{"key":"10.1016\/j.bcmd.2022.102709_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0901-5027(06)80062-7","article-title":"A comparison of glandular involvement between chronic graft-versus-host disease and Sj\u00f6gren's syndrome","volume":"25","author":"Hiroki","year":"1996","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bcmd.2022.102709_bb0085","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcmd.2022.102709_bb0090","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2133.1996.tb06314.x","article-title":"Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association","volume":"134","author":"Bell","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0095","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2133.2010.09667.x","article-title":"Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy","volume":"162","author":"Akay","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0100","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/bmt.2013.106","article-title":"Nailfold capillary abnormalities in sclerodermatous chronic GVHD","volume":"48","author":"Hofstee","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2022.102709_bb0105","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/rheumatology\/ker125","article-title":"Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin","volume":"50","author":"Aschwanden","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcmd.2022.102709_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006203","article-title":"Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis","volume":"4","author":"Fleming","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2022.102709_bb0115","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.bcmd.2022.102709_bb0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","article-title":"Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Saad","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979622000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979622000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:37:15Z","timestamp":1761050235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979622000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"alternative-id":["S1079979622000663"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2022.102709","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatological manifestations of chronic graft versus host disease - Case series","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2022.102709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102709"}}